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Abstract
Background:  T-cells extravasation and CNS parenchyma infiltration during autoimmune
neurodegenerative disease can be evoked by local antigen presenting cells. Studying the
chemoattracting potential of spinal perivascular macrophages (SPM) during experimental allergic
encephalomyelitis (EAE), we observed numerous infiltrates of densely-packed mononuclear cells.
Apart from the poor spatial and optical resolution, no differentiation between the resident SPM
(mabs ED1+, ED2+) and the just recruited monocytes/macrophages (mab ED1+) was possible.
Results: This is why we labeled SPM by injections of different fluoresecent dyes into the lateral
cerebral ventricle before induction of active EAE. Within an additional experimental set EAE was
induced by an intraperitoneal injection of T-cells specifically sensitized to myelin basic protein
(MBP) and engineered to express the green fluorescent protein (GFP). In both experiments we
observed a strong activation of SPM (mabs OX6+, SILK6+, CD40+, CD80+, CD86+) which was
accompanied by a consistently increased expression of ICAM-1, VCAM-1, and the chemokines
MCP-1 and MIP-1α .
Conclusion:  These observations indicate that SPM play a role in promoting lymphocyte
extravasation.
Background
Antigen specificity during an autoimmune attack is affect-
ed by antigen presentation and recognition, antigen ex-
pression and the response of target organs [1].
Accordingly, accumulating evidence shows that the ex-
travasation of lymphocytes into the CNS perivascular (Vir-
chow-Robin) space in the course of progressing
autoimmune disease may be initiated by resident antigen
presenting cells [2–4].
It is generally acknowledged that, under conditions of a
structurally intact blood-brain barrier, the cerebral/spinal
perivascular macrophages (CPM/SPM) are the antigen
presenting cells of the brain [5–9]. CPM/SPM exhibit mor-
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phological features consistent with macrophages [10], ex-
press the scavenger receptor [8], the Major
Histocompatibility Complex (MHC) class II glycoproteins
on their surface [6], and act as scavengers in the cerebral
blood-brain interface zone [11]. CPM/SPM retain the
phagocytosed material and remain within the perivascu-
lar space for up to 2 years [11], with a rather slow turnover
rate of about 6% per month [12]. Due to presence of Fc
and complement receptors on their surface and expres-
sion of macrophage specific antigens [5], CPM/SPM are
considered to be "the only macrophages found in the tis-
sues of the CNS" [13].
CPM/SPM differ from pericytes with respect to their mor-
phology and anatomic localization in the perivascular
space [14]. Pericytes are – like elsewhere in the body –
completely ensheathed by split layers of the vascular basal
lamina and separated from the CNS tissue by the mem-
brana limitans gliae perivascularis. CPM/SPM, on the con-
trary, are never enclosed within the basal lamina of the
blood vessels. In this way, placed along the lymphatic
drainage pathways of the brain, CPM/SPM are in a prime
position not only for antigen presentation, but also for in-
fluencing endothelial cells and leukocyte migration from
the blood [15].
This is why we decided to study their role in experimental
allergic encephalomyelitis (EAE), which is considered to
represent an animal model for multiple sclerosis [16].
Our special interest was focused on the immunocyto-
chemically detectable expression of cell adhesion mole-
cules and chemokines by CPM/SPM.
Observation of spinal-cord sections from rats with EAE,
however, revealed numerous densely-packed mononu-
clear cells in the Virchow-Robin space, which seriously
jeopardized the imunocytochemical differentiation be-
tween the resident SPM (mab ED2+, mab ED1+) and the
recently extravasated monocytes/macrophages (mab
ED1+, mab ED2-) [6,14,17].
To circumvent this poor spatial and optical resolution we
labeled SPM by intracerebroventricular (icv) injections of
different fluorescent dyes before induction of active EAE
(injection with myelin basic protein in complete Freund's
adjuvant). In additional experiments EAE was induced by
the intraperitoneal injection of T-cells specifically primed
to myelin basic protein (MBP) and engineered to express
the green fluorescent protein (GFP) [18,19].
In both sets of experiments we observed a strong activa-
tion of SPM (mabs OX6+, SILK6+, CD40+, CD80+,
CD86+) which was accompanied by a consistently in-
creased expression of ICAM-1, VCAM-1, and the chemok-
ines MCP-1 and MIP-1α . We conclude that, indicating the
sites for lymphocytic extravasation, SPM play an impor-
tant role in the initiation of local inflammatory processes.
Results
SPM in intact control animals
There was no diffuse staining indicative of free marker
substance in the spinal cord of both rat strains after injec-
tion of horseradish peroxidase (HRP), Fluoro-Emerald
(FE), or Fluoro-Ruby (FR) in the right lateral ventricle:
only the perivascular macrophages were labeled (arrows in
Fig. 1).
SPM in rats with active EAE at the peak of paraparesis
The SPM-labeling turned out to be extremely irregular af-
ter icv injection of any label in LEW/Han Rij Hsd rats at the
peak of EAE (severe paraparesis). In 11 out of 21 paraple-
gic animals we found no labeling in the spinal cord 24
hours after icv application (Fig. 2A). Since tracers could be
detected in the brain parenchyma around the injection
site, we attributed their lack in the lumbar spinal cord to
a blockade of the cerebrospinal-fluid circulation by the in-
flammatory oedema.
Observation of vibratome sections from the other 10 par-
aplegic rats revealed successful intensive labeling of the
perivascular macrophages in both brain as well as spinal
cord (arrows in Fig. 2B). Obviously in these animals the
CSF-circulation was not so strongly affected by the inflam-
matory oedema.
Unfortunately these sections failed to provide clearcut in-
formation about the relationship between SPM and lym-
phocytes during extravasation. The presence of well-
advanced lymphocytic infiltrates in the spinal cord paren-
chyma indicated that the extravasation had already oc-
curred. No spatial resolution of the various cellular
elements within these "perivascular cuffs" by convention-
al microscopy was possible (Fig. 2C, 2D). The electron mi-
croscopic analysis showed that a large portion of the HRP-
labeled SPM contained shrunken nuclei and vacuolated
scanty cytoplasm, i.e. displayed signs of degeneration
(Fig. 2E).
SPM in rats with transfer EAE at the peak of paraparesis
Following injection of TMBPGFP cells the syngenic LEW/
CRL BR rats developed the typical monophasic course of
EAE. The peak of paraparesis and incontinence was ob-
served 5 days after injection of TMBPGFP cells. The histo-
logical examination at this period revealed a massive
infiltration of the CNS with green fluorescent mononu-
clear cells (Fig. 3A, 3B). Their density was extremely irreg-
ular. Injection of 5% FR at the peak of paraparesis into the
lateral ventricle labeled the SPM in red (Fig. 3B) and al-
lowed unbiased observations of the relationship between
SPM and infiltrating lymphocytes.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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Figure 1
Labeling of spinal perivascular macrophages (SPM) after icv injection of horseradish peroxidase (HRP) and Fluoro-Emerald (FE).
Longitudinal section through the lumbar spinal cord of intact control animals showing SPM (arrows) labeled by HRP (A) and by
FE (B). 50 µm thick vibratome sections.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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Figure 2
Labeling of spinal perivascular macrophages (SPM) after icv injection of HRP in rats with EAE. A: Spinal cord of a rat with a
severe paraparesis showing large erythrocytic infiltrates but no labeling of SPM; 50 µm vibratome section. B: The successful
HRP-DAB labeling of SPM (arrows) in rats with EAE reveals more labeled SPM than in normal control animals; 50 µm vibratome
section. C: The dense perivascular leukocytic infiltrates in the spinal cord parenchyma of rats with severe paraparesis allow
only poor spatial resolution between the endothelial and extravasated cells in 50 µm thick vibratome sections. D: No differen-
tiation among the various types of extravasated cells filling the periavscular space was possible also in plastic semithin sections
(0.5 µm thick) counterstained with toluidine blue. E: Rat with severe paraparesis. Electron micrograph showing a HRP-labeled
SPM with vacuolated cytoplasm. Counterstaining with uranyl acetate and lead citrate.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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Figure 3
Vibratome section from the lumbar spinal cord of a rat in which EAE was induced by an intraperitoneal injection of 5 ×  106
TMBPGFP cells. A: Five days post application (peak of paraparesis) the green fluorescent autoaggressive T-lymphocytes (empty
arrows) have infiltrated both white and grey matter. B: The assumption that the bulk of TMBPGFP cells would stay in contact
with the red (FR-labeled) SPM (arrows) was wrong: most lymphocytes succeeded to find a way towards the CNS parenchyma.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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These new data falsified one expectation that had been
based on earlier work. Our hypothesis, that most (if not
all) of the red-fluorescent SPM would be approached and
contacted by the extravasated autoagressive lymphocytes,
turned out to be wrong. Despite a general impression that
some TMBPGFP cells adhered to SPM, most lymphocytes
found a way into the CNS parenchyma through the walls
of capillaries and venules which do not possess a SPM lin-
ing.
Thus, the invasion of leukocytes (non-labeled as well as
TMBPGFP cells) occurred despite the barrier role of SPM to
CNS infiltration which we had previously shown in a dif-
ferent kind of experiment [4]. Being a component of a
neuroprotective mechanism of extraparenchymal antigen
presentation and prevention of infiltrates, activated SPM
can impede blood cells from crossing the lamina superfi-
cialis gliae limitans and infiltrate CNS parenchyma under
conditions of a non-inflammatory immune response to exoge-
nous proteins[4]. During EAE, however, SPM fail to stop the
infiltration of CNS parenchyma by highly activated lym-
phocytes (primed against MBP). Obviously the degree of
T cell activation, the number of activated T cells, and the
localization of the target antigen in the CNS are all impor-
tant factors in determining the extent of intraparenchymal
T cell infiltration.
Immunlogical pertinence of the non-phagocytic cells
Many non-phagocytic cells in the spinal perivascular
space, which were not labeled by the icv applied fluores-
cent dyes, could be stained by the lymphocyte-recogniz-
ing antibodies R73, W3/25, and OX-50 (data not shown;
see however Fig. 4 in Walther et al., 2001) [4].
Activation of SPM during EAE
Estimating the degree of activation of SPM during EAE, we
found that the bulk of SPM, which were labeled and thus
identified by by icv injection with FE (Fig.
4A,4C,4E,4G,4I,4K) were ED2-positive [20], expressed
MHC class II glycoproteins, IL1-β , CD40-, and B7-mole-
cules (Figs. 4B,4D,4F,4H,4J,4L). Whereas the immunore-
activity for both the ED2-antigen and MHC class II
glycoproteins is constitutive and thus present also in un-
affected rats, there was no staining of SPM in spinal cord
sections from intact rats after incubation with SILK6, anti-
Figure 4
Activation of SPM in 50 µm vibratome sections from the spinal cord of rats with severe EAE. All cells which have been labeled
by icv application of FE (green in A,C,E) are ED2-positive (B), OX6-positive (D), SILK6-positive (F). G, H: Almost all FE-
labeled SPM express the CD40 molecule (CY3). I, J, K, L: FE-labeled SPM (I, K) express also the B7-1 (J) and the B7-2 (L)
molecule as detected by immunofluorescence with anti-CD80, anti-CD86, and CY3.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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CD40, anti-CD80, anti-CD86 (data not shown; see how-
ever the right column of Fig. 3 in Walther et al., 2001) [4].
Expression of cell adhesion molecules by SPM during EAE
To elucidate the putative chemoattracting potential of
SPM, which were labeled green by an icv injection of FE,
we investigated whether they expressed molecules pro-
moting extravasation of leukocytes. Despite the common
view that during ongoing inflammation the expression of
adhesion molecules by the cerebral endothelium is not
sufficient to support leukocyte recruitment [21–23], we
compared the expression of cell adhesion molecules be-
tween unaffected rats and animals with EAE. Following
incubation with polyclonal anti-ICAM-1 and anti-VCAM-
1 and visualization of the immunoreaction product by the
red fluorescence of Cy3, we observed much more immu-
nopositive SPM (orange-yellow fluorescence) in the para-
plegic rats (Fig. 5A,5C) than in the intact controls (Fig.
5B,5D). Although the numerous and densely-packed cells
in and around the Virchow-Robin space rendered difficult
the discrimination between endothelial cells, recruited
macrophages and activated SPM, these results are in line
with the earlier findings demonstrating expression of
VCAM-1 mRNA in cerebral perivascular macrophages in
the acute phase of immune-mediated injury [24].
Production of chemokines by SPM during EAE
Chemokines are proposed to play a role in CNS inflam-
matory disease at the stage of leukocyte recruitment in the
perivascular space in response to activated antigen-specif-
ic T-lymphocytes [25,26]. Together with their receptors
the chemokines build a complex and sophisticated bio-
chemical signaling system involved in the regulation of
leukocyte and lymphocyte trafficking [27,28]. Both, adhe-
sion molecule expression as well as production of chem-
okines within the CNS have been reported (reviewed in
Prat et al., 2001) [29]. However, sound morphological ev-
idence elucidating mechanism(s) by which precisely iden-
tified SPM (but not perivascular glial cells or perivascular
astrocytes) could promote extravasation of leukocytes
into the Virchow-Robin space and thus initiate inflamma-
tory relapses, is still missing.
The chemokines MCP-1 (monocyte chemoattractant pro-
tein) and MIP-1α  (macrophage inflammatory protein 1α )
are known to play crucial roles in recruiting macrophages
and monocytes [30–32]. Using monoclonal mouse anti-
bodies we observed more MCP-1 and MIP-1α  positive
SPM (Fig. 5E,5G) in animals with EAE than in intact con-
trol rats (Fig. 5F,5H).
Discussion
Clinical importance of T-cell extravasation
A major issue in the pathogenesis of any autoimmune
neurological disease is how autologous proteins, that had
been pathologically altered "behind" an intact blood-
brain barrier (BBB) can mediate T-lymphocyte entry into
the central nervous system (CNS) and trigger inflammato-
ry relapses [33]. These relapses consist of (i) early proin-
flammatory response, (ii) recruitment of antigen specific
T-lymphocytes, and (iii) invasion of leukocytes (mono-
cytes/macrophages, T- and B-lymphocytes) into the brain
parenchyma [34–38].
The last process listed, i.e. the accumulation of immune
effectors around the cerebral microvasculature ("perivas-
cular lymphocytic cuffs") is considered to initiate or exac-
erbate an inflammatory process, which is accompanied by
a localized breakdown of the blood-brain barrier to serum
proteins, leading to focal oedema [39,40]. The "bystander
demyelination" [41,42], together with the subsequent in-
terruption of axons [43,44], provide the pathologic corre-
late of irreversible neurologic impairment [45].
In contrast, the molecular mechanisms which rule the first
two processes, i.e. the proinflammatory response and the
subsequent CNS-recruitment of T-lymphocytes, remain
unclear. This lack of sound knowledge is very disappoint-
ing because in the course of many immune-mediated dis-
eases such as multiple sclerosis, postinfectious
encephalomyelitis, viral encephalitis, the entry of T-lym-
phocytes into the CNS is one of the earliest events in their
pathogenesis [46–48]. Morphologically, T-lymphocytes
have been shown to cross the BBB via a transendothelial
route, preferentially in parajunctional areas of endothelial
cells [49]. Interestingly, there appears to be a particularly
high density of endothelial adhesion molecule expression
in these areas [50]. Although the large number of T-lym-
phocytes seen in specific regions or plaques in the acute
stage of multiple sclerosis suggests that there is specific tar-
geting in the immune response [15], the basic mecha-
nisms ruling the extravasation of lymphocytes into the
perivascular (Virchow-Robin) space and the subsequent
infiltration of the brain-parenchyma have not been entire-
ly elucidated yet.
Possible role of T-cell receptors (TCR)
The generally accepted current theory is based on the fact
that CNS is continuously patrolled by activated T-lym-
phocytes [49–51]. Upon antigenic stimulation to a blast
phase [52] these lymphocytes which carry T cell receptors
(TCR) for CNS autoantigens initiate an "encephalitogenic
immune response", i.e. if these "antigen seeking" T-cells
encounter their antigen in the CNS [46,52–54] they could
promote an inflammatory reaction through the secretion
of pro-inflammatory cytokines [55–58]. This leads to the
upregulation of endothelial adhesion molecules and the
local production of chemokines, which in concert facili-
tate the entry of circulating B- and T-lymphocytes [59] and
inflammatory effector cells into the local lesion sites [60].BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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This "direct" or "chemotaxis-based" theory of extravasa-
tion and infiltration acknowledges the "site-specific lym-
phocyte entry" as a key event for the progression of disease
and outcome [21,36,61–63].
Possible role(s) of the resident antigen presenting cells
Since, however, the inflammation-triggering antigen rec-
ognition by T-lymphocytes can take place only after pres-
entation of antigen in association with the MHC class II
molecule, the role of the resident antigen presenting cells
(APC) during lymphocyte extravasation is a matter of con-
tinuously expanding interest [53,64–67]. Earlier work has
shown that the most probable candidate for antigen pres-
entation within the rat CNS are the ED2-positive CPM/
SPM [reviewed in [68]].
Due to their strategic location distal to the blood-en-
dothelial interface and proximal to the glia limitans,
CPM/SPM are able to phagocytize neuronal debris in the
cerebral interstitium and to contact extravasated T-lym-
phocytes [9,69]. CPM/SPM synthesize MHC class II glyco-
proteins constitutively and, following neuronal death,
transform into IL-1β  secreting neuronophages [70,71].
Recent evidence also implicates SPM as primary targets of
human immunodeficiency virus (HIV) and simian immu-
nodeficiency virus (SIV) infection in the CNS of humans
and macaques [72]. Anyway, these cells must not be
mixed up with other "sentinels" of the immune system
within the brain, e.g. the ED2-negative dendritic cells in
the meninges and choroid plexus [73].
Accordingly, current knowledge shows that since the syn-
thesis of T-cell receptors (TCR) is directly dependent on
the concentration of MHC class II peptides expressed by
APC [74], the latter are able to mediate the trafficking of
specific antigen-primed T-lymphocytes [75] or B-lym-
phocytes [76,77] into the cerebral area. Thus, the capacity
to activate lymphocytes for transfer of severe experimental
autoimmune encephalomyelitis has been attributed to
cerebral APC [2,75,78]. Furthermore, activating memory/
blast CD4+ T-lymphocytes through secretion of cytokines
[79,80] and co-stimulatory molecules, APC could play a
key role in the repetitive lymphocytic invasions and leu-
kocyte recruitment [81–83]. Finally, selective depletion of
blood-borne or resident perivascular macrophages during
EAE causes suppression of clinical symptoms [84–89].
Conclusions
In the present study we used a combination of a technique
for invasive, but very reliable labeling of SPM plus an im-
munocytochemcal analysis of their activity status. Study-
ing the reactivity of identified SPM in very small details,
this report provides evidence for increased expression of
cell adhesion molecules (ICAM-1, VCAM-1) and intensi-
fied production of chemokines (MCP-1, MIP-1α ) by SPM
during EAE. Since these findings, which could enhance T-
cell extravasation, were observed in both "antigen-in-
duced or active" and "T cell transfer-induced" forms of
EAE, we suppose that they reflect a common neurobio-
logical response of antigen-presenting SPM upon interac-
tion with primed T-lymphocytes.
Materials and Methods
Animals
Young adult (3 months of age) male Lewis rats were used:
Twenty-six animals were from the strain LEW/Han Rij Hsd
(purchased from Harlan Winkelmann, D-33176 Borchen,
Germany) and 16 rats from the strain LEW/CRL BR (pur-
chased from Charles River Deutschland, D-97633
Sulzfeld, Germany). Before and after experiments all rats
were kept on standard laboratory food and tap water ad li-
bitum with an artificial light-dark cycle of 12 hours light
on, 12 hours light off. All experiments were conducted in
accordance with the German law on Animal Protection
and all procedures were approved by the Local Animal-
Protection Committe (Bezirksregierung Köln, Az.
23.203.2-K 35, 33/98).
Overview of experiments
Sixteen LEW/Han Rij Hsd animals comprised the intact
control group and were used to optimize the labeling of
spinal perivascular macrophages (SPM) by intracerebrov-
entricular (icv) injections of horseradish peroxidase (HRP;
4 rats) or fluorochrome-conjugated dextrans (4 rats). Oth-
er 8 rats were used to immunocytochemically demon-
strate the basic expression of molecules promoting SPM
activation and lymphocyte extravasation.
The antigen-induced EAE (active EAE) group consisted
of 10 rats which were used to immunocytochemically
demonstrate the reactive changes in SPM during EAE.
The T cell transfer-induced EAE (transfer EAE) group
consisted of 16 LEW/CRL BR rats. Eight animals were used
as intact controls. The other 8 rats received an intraperito-
neal injection of 5 ×  106 autoaggressive MBP-specific T-
lymphocytes in 3 ml 10% FCS-containing medium. Since
these cells had been genetically engineered to express the
green fluorescent protein (GFP), they were readily detect-
able within the heterogenous perivascular infiltrates
("cuffs") in the spinal cord of rats with EAE [18]. A pre-
ceeding labeling of the SPM in red fluorescence (Fluoro-
Ruby) revealed the complex relationships between the res-
ident SPM and the extravasated GFP-transduced, MBP-
specific (TMBPGFP) lymphocytes.
Labeling of SPM employing intracerebroventricular (icv) 
injections
After an intraperitoneal injection of Ketamin plus Xylazin
(100 mg Ketanest® plus 5 mg Rompun® per kg bodyBMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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Figure 5
Expression of cell adhesion molecules and chemokines as revealed by double exposure pictures taken from in the lumbar spinal
cord of animals with EAE (A, C, E, G) and in intact rats (B, D, F, H). SPM have been labeled and identified by icv injection of
5% FE and fluoresce in green. The reaction product expressed by SPM has been visualized by FluoroLink™ Cy3™-Streptavidin,
which yields an orange-yellow fluorescence from the immunopositive SPM.BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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weight) the rats were fixed in a stereotactic apparatus and
received 35 µl of a 5% solution of horseradish peroxidase
(HRP, Type VIA, Sigma, No. P 6782), fluorescein-dextran
(Fluoro-Emerald, FE; Molecular Probes, Cat. No. D-1820)
or rhodamine-dextran (Fluoro-Ruby, FR; Molecular
Probes D-1817) in 0.9% NaCl saline into the right lateral
cerebral ventricle. All solutions were injected over a period
of 5 min [90] using a very thin (10 µm thick) glass pipette
to minimize tissue damage [91].
Induction of experimental allergic encephalomyelitis 
(EAE)
EAE was induced in 37 LEW/Han Rij Hsd rats by a single
intradermal (hind footpad) injection containing 25 µg
myelin basic protein from guinea pig (MBP; Sigma
M2295), 100 µg Mycobacterium tuberculosis H37 RA
(Difco Laboratories, Cat. Nr. 3114-33-8) in 50 µl Com-
plete Freund's Adjuvant (CFA; Difco Laboratories, Cat. Nr.
0638-60-7).
Tissue processing
Fixation
All rats were anesthetized with ether, their vascular system
rinsed for 60 sec with 0.9% NaCl saline and fixed for at
least 40 min by transcardial perfusion with 1.0 litre of
periodate-lysine-paraformaldehyde (PLP) fixative [92].
The PLP fixative was separately mixed from premade stem
stock solutions immediately prior to the perfusion of each
animal. The CNS (cerebrum, cerebellum, brainstem, spi-
nal cord) was removed and stored in a 4% (w/v) parafor-
maldehyde in 0.1 M phosphate buffer, pH 7,4.
Visualizing of HRP-labeled SPM
In contrast to our previous work [4] we focused our obser-
vations on the lumbar spinal cord only: Since the major
visible symptom during EAE is the severe paraparesis of
the hind limbs, most of the pathological alterations
should be expected, localized and observed in this region.
Longitudinal vibratome sections (50 µm thick) of the spi-
nal cord were incubated for 20 min in 0.75% (w/v) 3,3'-
diaminobenzidine tetrahydrochloride (150 mg in 200 ml
buffer; DAB, Sigma, D 5637) plus 0.01% (v/v) H2O2 plus
0.075% (w/v) nickel chloride in 0.05 M Tris-HCl buffer,
pH 7.6. This procedure yielded a very intensive dark-pur-
ple to black reaction product exclusively in the cytoplasm
of the SPM. Control tissue (sections from brains which
had not received HRP injections) contained no reaction
product. For electron microscopy some of the sections
were postfixed in 1% OsO4 + 1.5% K3
IIIFe(CN)6[93], de-
hydrated in graded acetones, and embedded flat in Arald-
ite CY212 (Fluka, No. 44610).
Visualizing of FE- and FR-labeled SPM
To detect the green fluorescence of FE or the red fluores-
cence of FR vibratome sections (50 µm thick) of the spinal
cord were illuminated through filter set 10 (excitation BP
450-490, beamsplitter FT 510, emission BP 515-565) or
filter set 15 (Excitation BP 546/12, Emission LP 590) of a
Carl Zeiss microscope.
Immunocytochemistry
Primary antibodies
(1) Mouse monoclonal OX-6 (Serotec, MCA 46, 1:1000)
recognizing rat MHC class II (Ia) antigen. (2) Mouse mon-
oclonal SILK 6 (Serotec, MCA-1397, 1:500) recognizing
recombinant rat IL-1β . (3) Armenian hamster mono-
clonal anti-mouse CD40 (BD PharMingen, 09401A,
1:100) to test for presence of the costimulatory molecule
CD40 on SPM. (4) Mouse monoclonal CD80 (BD
PharMingen, 22661D, 1:100) to test for presence of the
co-stimulatory molecule B7-1 on rat SPM. (5) Mouse
monoclonal CD86 (BD PharMingen, 22671D, 1:100) to
test for presence of the co-stimulatory molecule B7-2 on
rat SPM. (6) Monoclonal mouse anti-rat TCR alpha/beta
(clone R73, Serotec MCA 453G, 1:20) recognizing a con-
stant determinant of the α /β  T cell receptor. (7) Mono-
clonal mouse anti-rat CD4 (clone number W3/25, Serotec
MCA55G, 1:50) recognizing the CD4 cell surface glyco-
protein expressed by helper T cells and thymocytes. (8)
Monoclonal mouse anti-rat CD44 (clone OX-50, Serotec
MCA643XZ, 1:50) recognizing the CD44 cell surface anti-
gen expressed by T cells, B cells, macrophages, and thymo-
cytes. (9) Polyclonal goat anti-rat ICAM-1(M-19; Santa
Cruz Biotechnology Inc., sc-1511, 1:50) recognizing rat
intercellular adhesion molecule-1. (10) Polyclonal goat
anti-rat VCAM-1(C-19; Santa Cruz Biotechnology Inc., sc-
1504, 1:50) recognizing rat vascular cell adhesion mole-
cule-1. (11) Polyclonal rabbit anti-rat MCP-1 (Cedarlane,
No. CL9576AP, 1:500). recognizing the CC-chemokine
"monocyte chemoattractant protein-1" which promotes
the directed migration of inflammatory cells. (12) Poly-
clonal rabbit anti-rat MIP-1α  (Cedarlane, No. CL9577AP,
1:2000) recognizing the chemokine "macrophage inflam-
matory protein-1α  ".
Secondary antibodies
(1) Biotinylated goat anti-rabbit IgG (DAKO, No. E0432).
(2) Biotinylated goat anti-mouse IgG (Fab-specific, Sigma,
B-0529). (3) Biotinylated goat anti-mouse IgG (Fc specif-
ic, pre-absorbed with human IgG and rat serum proteins,
Sigma, No. B-9904). (4) Biotinylated rabbit anti-goat IgG
(DAKO, No. E0466). In order to minimize the back-
ground staining of neurons the biotinylated IgGs were al-
ways pre-absorbed with the individual rat's spleen protein
[70]. (5) Biotin-conjugated mouse anti-hamster IgG
(cocktail; PharMingen, 12102D).
Standard incubation protocol
Free floating vibratome sections were immunostained on
a shaker at room temperature through the following steps:BMC Immunology 2002, 3 http://www.biomedcentral.com/1471-2172/3/11
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(1) 0.6% (v/v) H2O2 in buffer (to block the endogenous
peroxidase activity) for 30 min; (2) 5.0% (w/v) bovine se-
rum albumin (BSA, Sigma No. A-9647) in 0.1 M Tris-buff-
ered saline (TBS) pH 7.6 for 60 min; (3) primary antibody
(see above) diluted in TBS plus 0.8% (w/v) BSA for 2 h;
(4) 5.0% (v/v) normal goat serum (NGS, Vector No. S-
1000) or normal rabbit serum (NRS, DAKO, No. X0902)
plus 0.8% BSA in TBS for 15 min. (5) 1:400 dilution of the
corresponding biotinylated secondary antibody in TBS for
1 h; (6) 1:100 diluted FluoroLink™ Cy2™-Streptavidin
(Amersham Life Science, PA 42001) or FluoroLink™
Cy3™-Streptavidin (Amersham Life Science, PA 43001)
for 1 h. Steps (1) and (5) were followed by two 10 min
washes in TBS. Steps (3) and (6) were followed by four 10
min washes in TBS. Finally, sections were dehydrated with
ethanol and Histoclear (a nontoxic xylene-substitute) and
coverslipped.
Controls
Omission of the primary or secondary antibody yielded
blank sections in which only the green SPM fluoresced.
Incubation of sections with non-relevant biotinylated sec-
ondary antibodies (e.g. goat anti-rabbit IgG for recogni-
tion of mouse primary antibodies) yielded also blank
sections.
Fluorescence microscopy
FE-labeled SPM and Cy2-immunopositive cells were visu-
alized through filter set 10 of a Carl Zeiss fluorescence mi-
croscope. FR-labeled SPM and Cy3-immunopositive cells
were observed through Zeiss filter set 15 (excitation
BP546/12, beamsplitter FT580, emission LP590). Both
FE-labeled SPM and CY3-immunopositive cells could be
simultaneously observed employing Zeiss filter set 25 (ex-
citation TBP400/495/570, beamsplitter FT410/505/585,
emission TBP460/530/610).
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